Rachel Wattier
Assistant Professor
Medical Director, Antimicrobial Stewardship Program
+1 415 514-0509
+1 415 476-1343

Biography

Rachel Wattier, M.D., M.H.S., who joined the Department of Pediatrics, Division of Infectious Diseases and Global Health in July 2015, serves as Medical Director of the Pediatric Antimicrobial Stewardship Program at UCSF Benioff Children’s Hospital San Francisco. In this role, she collaborates with pharmacists, nurses and physicians to ensure that patients receive timely therapy with the right antibiotic, at the right dose, for the right duration, with appropriate de-escalation when antibiotics are no longer needed.

Dr. Wattier provides care to patients on the inpatient Pediatric Infectious Diseases Consultation Service and outpatient Pediatric Infectious Diseases Clinic. She is a member of the UCSF Immunocompromised Host Infectious Diseases Program and is involved in clinical research and care for children immunocompromised due to transplantation, chemotherapy, or primary immunodeficiencies. She is involved in multicenter research protocols through the International Pediatric Fungal Network and other pediatric research collaborations.

Education and Training

Fellowship, 06/2015 Clinical Pharmacology, University of California, San Francisco
Fellowship, 06/2015 Pediatric Infectious Diseases, University of California, San Francisco
Certificate Program, 05/2015 Advanced Training in Clinical Research, University of California, San Francisco
Residency, 06/2012 Pediatrics, University of California, San Francisco
M.D., M.H.S., 05/2009 School of Medicine, Yale University
B.S., 05/2004 Biology, Agricultural Biotechnology, University of Kentucky

Publications

Cordoro KM, Reynolds SD, Wattier R, McCalmont TH. Clustered Cases of Acral Perniosis: Clinical Features, Histopathology and Relationship to COVID-19. Pediatr Dermatol. 2020 May 12.
Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, Yarbrough A, Abzug MJ, MacBrayne CE, Soma VL, Dulek DE, Vora SB, Waghmare A, Wolf J, Olivero R, Grapentine S, Wattier RL, Bio L, Cross SJ, Dillman NO, Downes KJ, Timberlake K, Young J, Orscheln RC, Tamma PD, Schwenk HT, Zachariah P, Aldrich M, Goldman DL, Groves HE, Lamb GS, Tribble AC, Hersh AL, Thorell EA, Denison MR, Ratner AJ, Newland JG, Nakamura MM. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatric Infect Dis Soc. 2020 Apr 22.
Singh P, Steurer MA, Cantey JB, Wattier RL. Hospital-level Antibiotic Use and Complexity of Care Among Neonates. J Pediatric Infect Dis Soc. 2019 Dec 27.
Jennifer E Schuster, Jennifer E Schuster, Andrew Speaker, Lubna Hamdan, Einas Batarseh, Laura S Stewart, Daniel Dulek, Carrie L Kitko, Flor M Munoz, Flor M Munoz, Claire Bocchini, Lara Danziger-Isakov, Michael Grimley, Rakesh Goyal, Susan E Coffin, Jason L Freedman, Janet A Englund, Paul A Carpenter, Monica I Ardura, Jeffrey Auletta, Rachel Wattier, Kenny Truong, Gabriela Maron, Kim J Allison, Natasha B Halasa. 2759. Immunogenicity of Inactivated Influenza Vaccines Given Early vs. Late After Pediatric Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases. 2019 Oct 23; 6(Suppl 2):s972-s973.
Benjamin T, Wattier R, Dominic W. Allograft of Primary Cutaneous Mucormycosis in a Preterm Neonate: A Case Report. Wounds. 2019 Jul; 31(7):E46-E48.
Prachi Singh, Rachel Wattier. 258. Variation in Antibiotic Use Among Neonates Hospitalized in United States Academically Affiliated Centers. Open Forum Infectious Diseases. 2018 Nov 26; 5(suppl_1):s109-s109.
Rachel L. Wattier, William J. Steinbach. 293 Antifungal Agents. Principles and Practice of Pediatric Infectious Diseases. 2018 Jan 1; (Clin Infect Dis442007):1532-1541.e3.
Wattier RL, Levy ER, Sabnis AJ, Dvorak CC, Auerbach AD. Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infect Control Hosp Epidemiol. 2017 09; 38(9):1039-1047.
Esbenshade AJ, Zhao Z, Aftandilian C, Saab R, Wattier RL, Beauchemin M, Miller TP, Wilkes JJ, Kelly MJ, Fernbach A, Jeng M, Schwartz CL, Dvorak CC, Shyr Y, Moons KGM, Sulis ML, Friedman DL. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia. Cancer. 2017 Oct 01; 123(19):3781-3790.
Wattier RL, Ramirez-Avila L. Pediatric Invasive Aspergillosis. J Fungi (Basel). 2016 Jun 13; 2(2).
Wattier RL, Ramirez-Avila L. Pediatric invasive aspergillosis. Journal of Fungi. 2016; 19(2).
Horn B, O'Kane S, Wattier RL, Wahlstrom JT, Melton A, Cowan MJ, Dvorak CC. Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab. Bone Marrow Transplant. 2016 11; 51(11):1510-1512.
Biljana Horn, Sara O'Kane, Rachel Wattier, Justin T. Wahlstrom, Alexis Melton, Morton J. Cowan, Christopher C. Dvorak. Serotherapy-Related Fevers, Blood Stream Infections (BSI), and Antibiotic Use in Pediatric Allogeneic Hematopoietic Cell Transplant (HCT) Recipients. Biology of Blood and Marrow Transplantation. 2016 Mar 1; 22(3):s246-s247.
Wattier RL, Dvorak CC, Auerbach AD, Weintrub PS. Repeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implications. Pediatr Blood Cancer. 2015 Aug; 62(8):1421-6.
Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin-Hussain I, Groll AH, Castagnola E, Knapp KM, Zaoutis TE, Gustafsson B, Sung L, Berman D, Halasa NB, Abzug MJ, Velegraki A, Sharma TS, Fisher BT, Steinbach WJ. A Prospective, International Cohort Study of Invasive Mold Infections in Children. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):313-22.
Levitz R, Wattier R, Phillips P, Solomon A, Lawler J, Lazar I, Weibel C, Kahn JS. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific. Virol J. 2012 Sep 10; 9:190.
Wattier RL, Vázquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, Kahn JS. Role of human polyomaviruses in respiratory tract disease in young children. Emerg Infect Dis. 2008 Nov; 14(11):1766-8.
von Lackum K, Babb K, Riley SP, Wattier RL, Bykowski T, Stevenson B. Functionality of Borrelia burgdorferi LuxS: the Lyme disease spirochete produces and responds to the pheromone autoinducer-2 and lacks a complete activated-methyl cycle. Int J Med Microbiol. 2006 May; 296 Suppl 40:92-102.
Babb K, von Lackum K, Wattier RL, Riley SP, Stevenson B. Synthesis of autoinducer 2 by the lyme disease spirochete, Borrelia burgdorferi. J Bacteriol. 2005 May; 187(9):3079-87.
Stevenson B, von Lackum K, Wattier RL, McAlister JD, Miller JC, Babb K. Quorum sensing by the Lyme disease spirochete. Microbes Infect. 2003 Sep; 5(11):991-7.